₹22.5*
MRP ₹25
10% off
₹21.25*
MRP ₹25
15% CB
₹3.75 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
पर्यायवाची :
डाइसाइक्लोमाइन हाइड्रोक्लोराइड+मेफेनैमिक एसिड
सेवन का प्रकार :
मौखिक
वापसी नीति :
वापसी योग्य नहीं
Drug-Drug Interactions
DicyclominePotassium citrate
Critical
DicyclominePramlintide
Critical
Drug-Drug Interactions
Login/Sign Up
DicyclominePotassium citrate
Critical
How does the drug interact with Unispas 10 mg/250 mg Tablet:
Taking Unispas 10 mg/250 mg Tablet and Potassium citrate together can increase the risk of stomach ulcers, bleeding, and gastrointestinal injury.
How to manage the interaction:
Taking Unispas 10 mg/250 mg Tablet with Potassium citrate is not recommended, as it may lead to an interaction, it can be taken if prescribed by the doctor. However, if you experience severe stomach pain, bloating, sudden lightheadedness or dizziness, nausea, vomiting (especially with blood), decreased hunger, or dark, tarry stools, consult the doctor immediately. Do not discontinue any medications without a doctor's advice.
Taking Unispas 10 mg/250 mg Tablet and Potassium citrate together can increase the risk of stomach ulcers, bleeding, and gastrointestinal injury.
How to manage the interaction:
Taking Unispas 10 mg/250 mg Tablet with Potassium citrate is not recommended, as it may lead to an interaction, it can be taken if prescribed by the doctor. However, if you experience severe stomach pain, bloating, sudden lightheadedness or dizziness, nausea, vomiting (especially with blood), decreased hunger, or dark, tarry stools, consult the doctor immediately. Do not discontinue any medications without a doctor's advice.
DicyclominePramlintide
Critical
How does the drug interact with Unispas 10 mg/250 mg Tablet:
Co-administration of Pramlintide with Unispas 10 mg/250 mg Tablet can increase the risk of reduced gastrointestinal movement.
How to manage the interaction:
Taking Unispas 10 mg/250 mg Tablet with Pramlintide is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
Co-administration of Pramlintide with Unispas 10 mg/250 mg Tablet can increase the risk of reduced gastrointestinal movement.
How to manage the interaction:
Taking Unispas 10 mg/250 mg Tablet with Pramlintide is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
Critical
How does the drug interact with Unispas 10 mg/250 mg Tablet:
Co-administration of Unispas 10 mg/250 mg Tablet with Potassium chloride can increase the risk of stomach ulcers.
How to manage the interaction:
Taking Unispas 10 mg/250 mg Tablet with Potassium chloride is not recommended, as it can lead to an interaction, it can be taken if a doctor has prescribed it. However, if you experience severe stomach pain, bloating, sudden lightheadedness or dizziness, nausea, vomiting (especially with blood), decreased hunger, dark, tarry stools, consult the doctor immediately. Do not discontinue the medication without consulting a doctor.
Co-administration of Unispas 10 mg/250 mg Tablet with Potassium chloride can increase the risk of stomach ulcers.
How to manage the interaction:
Taking Unispas 10 mg/250 mg Tablet with Potassium chloride is not recommended, as it can lead to an interaction, it can be taken if a doctor has prescribed it. However, if you experience severe stomach pain, bloating, sudden lightheadedness or dizziness, nausea, vomiting (especially with blood), decreased hunger, dark, tarry stools, consult the doctor immediately. Do not discontinue the medication without consulting a doctor.
Critical
How does the drug interact with Unispas 10 mg/250 mg Tablet:
Coadministration of Unispas 10 mg/250 mg Tablet with Ketorolac can increase the risk or severity of gastric bleeding and ulcers.
How to manage the interaction:
Taking Unispas 10 mg/250 mg Tablet with Ketorolac together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Coadministration of Unispas 10 mg/250 mg Tablet with Ketorolac can increase the risk or severity of gastric bleeding and ulcers.
How to manage the interaction:
Taking Unispas 10 mg/250 mg Tablet with Ketorolac together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Critical
How does the drug interact with Unispas 10 mg/250 mg Tablet:
Co-administration of Unispas 10 mg/250 mg Tablet with Meloxicam together can increase the risk or severity of bleeding.
How to manage the interaction:
Taking Unispas 10 mg/250 mg Tablet with Meloxicam together is generally avoided as it can result in an interaction, it can be taken if a doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking a doctor.
Co-administration of Unispas 10 mg/250 mg Tablet with Meloxicam together can increase the risk or severity of bleeding.
How to manage the interaction:
Taking Unispas 10 mg/250 mg Tablet with Meloxicam together is generally avoided as it can result in an interaction, it can be taken if a doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking a doctor.
Severe
How does the drug interact with Unispas 10 mg/250 mg Tablet:
Co-administration of Unispas 10 mg/250 mg Tablet with Topiramate may worsen effects like increased body temperature and sweating.
How to manage the interaction:
If you have to use Unispas 10 mg/250 mg Tablet and Topiramate together, your doctor may adjust the dose or monitor you more frequently to safely use both medications. Drink plenty of fluids during warm weather and when exercising and contact a doctor if you have decreased sweating or a fever. You may also experience drowsiness, dizziness, or lightheadedness when taking these medications together. Do not discontinue the medication without consulting a doctor.
Co-administration of Unispas 10 mg/250 mg Tablet with Topiramate may worsen effects like increased body temperature and sweating.
How to manage the interaction:
If you have to use Unispas 10 mg/250 mg Tablet and Topiramate together, your doctor may adjust the dose or monitor you more frequently to safely use both medications. Drink plenty of fluids during warm weather and when exercising and contact a doctor if you have decreased sweating or a fever. You may also experience drowsiness, dizziness, or lightheadedness when taking these medications together. Do not discontinue the medication without consulting a doctor.
DicyclomineSecretin
Severe
How does the drug interact with Unispas 10 mg/250 mg Tablet:
Co-administration of Secretin human with Unispas 10 mg/250 mg Tablet may decrease the therapeutic efficacy of Secretin human.
How to manage the interaction:
Taking Unispas 10 mg/250 mg Tablet with Secretin together can possibly result in an interaction, but it can be taken if your doctor has advised it. Do not discontinue any medications without first consulting your doctor.
Co-administration of Secretin human with Unispas 10 mg/250 mg Tablet may decrease the therapeutic efficacy of Secretin human.
How to manage the interaction:
Taking Unispas 10 mg/250 mg Tablet with Secretin together can possibly result in an interaction, but it can be taken if your doctor has advised it. Do not discontinue any medications without first consulting your doctor.
Severe
How does the drug interact with Unispas 10 mg/250 mg Tablet:
Co-administration of Unispas 10 mg/250 mg Tablet with Zonisamide may worsen effects like increased body temperature and sweating.
How to manage the interaction:
If you have to use Unispas 10 mg/250 mg Tablet and Zonisamide together, your doctor may adjust the dose or monitor you more frequently to safely use both medications. You may also experience drowsiness, dizziness, or lightheadedness when taking these medications together. Do not discontinue any medication without consulting a doctor.
Co-administration of Unispas 10 mg/250 mg Tablet with Zonisamide may worsen effects like increased body temperature and sweating.
How to manage the interaction:
If you have to use Unispas 10 mg/250 mg Tablet and Zonisamide together, your doctor may adjust the dose or monitor you more frequently to safely use both medications. You may also experience drowsiness, dizziness, or lightheadedness when taking these medications together. Do not discontinue any medication without consulting a doctor.
How does the drug interact with Unispas 10 mg/250 mg Tablet:
Coadministration of Unispas 10 mg/250 mg Tablet with Dabigatran can increase the risk or severity of bleeding leading to serious blood loss.
How to manage the interaction:
Taking Unispas 10 mg/250 mg Tablet with Dabigatran etexilate together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Coadministration of Unispas 10 mg/250 mg Tablet with Dabigatran can increase the risk or severity of bleeding leading to serious blood loss.
How to manage the interaction:
Taking Unispas 10 mg/250 mg Tablet with Dabigatran etexilate together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Severe
How does the drug interact with Unispas 10 mg/250 mg Tablet:
Co-administration of Unispas 10 mg/250 mg Tablet with Lithium can increase Lithium levels in the body.
How to manage the interaction:
Taking Unispas 10 mg/250 mg Tablet with Lithium together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any drowsiness, dizziness, confusion, loose stools, vomiting, muscle weakness, muscle incoordination, shaking of hands and legs, blurred vision, ringing in the ear, excessive thirst, and/or increased urination, contact a doctor. Do not stop using any medications without talking to a doctor.
Co-administration of Unispas 10 mg/250 mg Tablet with Lithium can increase Lithium levels in the body.
How to manage the interaction:
Taking Unispas 10 mg/250 mg Tablet with Lithium together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any drowsiness, dizziness, confusion, loose stools, vomiting, muscle weakness, muscle incoordination, shaking of hands and legs, blurred vision, ringing in the ear, excessive thirst, and/or increased urination, contact a doctor. Do not stop using any medications without talking to a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Product Substitutes
शराब
असुरक्षित
Unispas 10 mg/250 mg Tablet लेते समय शराब के सेवन से बचें क्योंकि इससे उनींदापन बढ़ सकता है। यह पेट से खून बहने का खतरा भी बढ़ा सकता है।
गर्भावस्था
सावधानी
यदि आप गर्भवती हैं या इस बारे में कोई चिंता है तो कृपया अपने चिकित्सक से परामर्श करें; आपका डॉक्टर केवल तभी दवा लिखेगा जब लाभ जोखिमों से अधिक हों।
स्तनपान
असुरक्षित
Unispas 10 mg/250 mg Tablet लेते समय स्तनपान कराने की सलाह नहीं दी जाती है। यदि आप स्तनपान करा रही हैं तो Unispas 10 mg/250 mg Tablet लेने से पहले अपने चिकित्सक से परामर्श करें।
ड्राइविंग
सावधानी
Unispas 10 mg/250 mg Tablet से उनींदापन और चक्कर आ सकते हैं। जब तक आप सतर्क न हों, तब तक गाड़ी न चलाएं या मशीनरी न चलाएं।
लीवर
सावधानी
लीवर की समस्या वाले मरीजों में खुराक समायोजन की आवश्यकता हो सकती है। कृपया अपने चिकित्सक से परामर्श करें यदि आपको लीवर की कोई समस्या है या इस बारे में कोई चिंता है।
किडनी
असुरक्षित
गुर्दे की बीमारी वाले मरीजों को Unispas 10 mg/250 mg Tablet का इस्तेमाल नहीं करना चाहिए। कृपया अपने चिकित्सक से परामर्श करें यदि आपको किडनी की कोई समस्या है या इस बारे में कोई चिंता है।
बच्चे
असुरक्षित
बच्चों के लिए Unispas 10 mg/250 mg Tablet की सिफारिश नहीं की जाती है क्योंकि सुरक्षा और प्रभावशीलता स्थापित नहीं की गई थी।
Have a query?
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
